Zdrowie i gospodarka · 23/04/2001

FDA Confirms Effective Date for Revised Anti-Human Globulin Regulations

The US Food and Drug Administration (FDA) has confirmed the effective date of June 11, 2001, for a revised rule that relaxed the sterility requirement for licensed Anti-Human Globulin and Blood Grouping Reagents, as published in the Federal Register on December 12, 2000.